C-MYC oncogene family expression in glioblastoma and survival

Surgical Neurology

Volumn 51, Issue 5, 1999, Pages 536-542

  Herms, Jochen W ^a   Von Loewenich, Friederike D ^a   Behnke, Julianne ^a   Markakis, Evangelos ^a   Kretzschmar, Hans A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

C myc; Glioblastoma; L myc; Max; N myc; Proto oncogenes; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; MALE; ONCOGENE C MYC; PROGNOSIS; PROTO ONCOGENE; SURVIVAL TIME;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS;

EID: 0032915057     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(98)00028-7     Document Type: Article

References (32)

1. Albarosa R., DiDonato S., Finocchiaro G. Redefinition of the coding sequence of the MXI1 gene and identification of a polymorphic repeat in the 3′ non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas. Hum Genet. 95:1995;709-711.
2. Ayer D.E., Kretzner L., Eisenman R.N. Mad a heterodimeric partner for Max that antagonizes Myc transcriptional activity . Cell. 72:1993;211-222.
3. Batra S.K., Rasheed B.K.A., Bigner S.H., Bigner D.D. Biology of disease, oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest. 71:1994;621-637.
4. Bigner S.H., Burger P.C., Wong A.J., Werner M.H., Hamilton S.R., Muhlbaier L.H., Vogelstein B., Bigner D.D. Gen amplification in malignant human gliomas clinical and histopathological aspects . J Neuropathol Exp Neurol. 47:1988;191-205.
5. Blackwood E.M., Eisenman R.N. Max a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc . Science. 51:1991;1211-1217.
6. Burger P.C., Green S.B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 59:1987;1617-1625.
7. Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings, Ed. 3. New York: Churchill Livingstone, 1991.
8. Chattopadhyay P., Banerjee M., Sakar C., Mathur M., Mohapatra A.K., Sinha S. Infrequent alteration of the c-myc gene in human glial tumours associated with increased number of c-myc positive cells. Oncogene. 11:1995;2711-2714.
9. Diedrich U., Soja S., Behnke J., Zoll B. Amplification of the c-erb oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol. 238:1991;221-224.
10. DePinho R., Schreiber-Agus N., Alt F.W. Myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res. 57:1991;1-46.
11. Edelhoff S., Ayer D.E., Zervos A.S., Steingrímsson E., Jenkins N.A., Copeland N.G., Eisenman R.N., Brent R., Disteche C.M. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19 . Oncogene. 9:1994;665-668.
12. Fujimoto M., Sheridan P.J., Sharp Z.D., Weaker F.J., Kagan-Hallet K.S., Story J.L. Proto-oncogene analyses in brain tumors. J Neurosurg. 70:1989;910-915.
13. Fujimoto M., Fults D.W., Thomas G.A., Nakamura Y., Heilbrun M.P., White R., Story J.L., Naylor S.L., Kagan-Hallet K.S., Sheridan P.J. Loss of heterozygosity on chromosome 10 in human glioblastoma. Genomics. 4:1989;210-214.
14. Henriksson M., Lüscher B. Proteins of the Myc Network essential regulators of cell growth and differentiation . Adv Cancer Res. 68:1996;109-182.
15. Herms J., Zurmöhle U., Schlingensiepen K.H., Brysch W. Transient expression of PKCγ mRNA in cerebellar granule cells during rat brain development. Neuro Report. 4:1993;899-902.
16. Herms J., Zurmöhle U., Schlingensiepen R., Brysch W., Schlingensiepen K.H. Developmental expression of the transcription factor zif268 in rat brain. Neurosci Lett. 165:1994;171-174.
17. Hirvonen H.E., Salonen R., Sandberg M.M., Vuorio E., Västrik I., Kotilainen E., Kalimo H. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer. 69:1994;16-25.
18. Hurlin P.J., Quéva C., Koskinen P.J., Steingrímsson E., Ayer D.E., Copeland N.G., Jenkins N.A., Eisenman R.N. Mad3 and Mad4 novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation . EMBO J. 14:1995;5646-5659.
19. Hurtt M.R., Moossy J., Donovan-Peluso M., Locker J. Amplification of epidermal growth factor receptor gene in gliomas histopathology and prognosis . J Neuropathol Exp Neurol. 51:1992;84-90.
20. James C.D., Carlbom E., Nordenskjold M., Collins V.P., Cavenee W.K. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA. 86:1989;2858-2862.
21. Kleihues P, Burger PC, Scheithauer BW, in collaboration with Sobin LH and pathologists in 14 countries. Histological typing of tumours of the central nervous system, Ed. 2. Berlin: Springer Verlag, 1993.
22. LaRocca R.V., Rosenblum M., Westermark B., Israel M.A. Patterns of proto-oncogene expression in human glioma cell lines. J Neurosci Res. 24:1989;97-106.
23. Lindeman G.J., Harris A.W., Bath M.L., Eisenman R.N., Adams J.M. Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice. Oncogene. 10:1995;1013-1017.
24. Oberstrass J., Ring G.U., Vogeley K.T., Kramm C.M., Cobbers M.L., Wirths J., Bilzer T., Wechsler W. Loss of heterozygosity on chromosome 10q21-26 in malignant gliomas. Verh Dtsch Ges Pathol. 78:1994;413-417.
25. Nisen P.D., Zimmerman K.A., Cotter S.V., Gilbert F., Alt F.W. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res. 46:1986;6217-6222.
26. Orian J.M., Vasilopoulos K., Yoshida S., Kaye A.H., Chow C.W., Gonzales M.F. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer. 66:1992;106-112.
27. Pigott T.J.D., Robson D.K., Palmer J., Ward L.M. Expression of epidermal growth factor receptor in human glioblastoma multiforme. Br J Neurosurg. 7:1993;261-265.
28. Rasheed B.K.A., McLendon R.E., Herndon J.E., Friedman H.S., Friedman A.H., Bigner D.D., Bigner S.H. Alterations of the TP53 gene in human gliomas. Cancer Res. 54:1994;1324-1330.
29. Trent J., Meltzer P., Rosenblum M., Harsh G., Kinzler K., Mashal R., Feinberg A., Vogelstein B. Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci. 83:1986;470-473.
30. von Deimling A., Eibl R.H., Ohgaki H., Louis D.N., von Ammon K., Petersen I., Kleihues P., Chung R.Y., Wiestler O.D., Seitzinger B.R. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 52:1992;2987-2990.
31. von Deimling A., von Ammon K., Schoenfeld D., Wiestler O.D., Seizinger B.R., Louis D.N. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 3:1993;19-26.
32. Zervos A., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 72:1993;223-232.